European Society for Medical Oncology

On Saturday, Pfizer Inc (NYSE: PFE) presented positive trial data for experimental drug designed for patients suffering from cancer cachexia during the European Society for Medical Oncology 2024 Congress. Affecting as many as 9 million people across the globe, cancer cachexia is a life-...

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. With interim results from a pivotal clinical trial of its lead PD-L1 checkpoint inhibitor incoming, biotech firm Checkpoint Therapeutics (...

Biotech stocks put up a muted performance in the week ended Sept. 20 amid conference presentations and FDA approvals. Johnson & Johnson (NYSE: JNJ)'s Janssen unit received an FDA nod for label expansion for its prostate cancer drug Erleada, and Eisai Co., Ltd (OTC: ESALY)'s Lenvantinib...

The 2018 European Society for Medical Oncology Congress started Oct. 19 and runs through Oct. 23. Presentations at the congress over the weekend created flutter among stocks of large-cap pharma and biotech companies. Although at the outset most data looked promising, sifting through the nitty-...

BMO Capital’s M. Ian Somaiya expects higher probability of success for Incyte Corporation (NASDAQ: INCY)'s epacadostat+Keytruda trials in melanoma, given the PFS strength in the updated Phase I data presented at the meeting of the European Society for Medical Oncology. Somaiya maintains an...